GENE ONLINE|News &
Opinion
Blog

2021-08-17| M&A

Booming Bioanalytical CRO Sets Sights on Australian Market with 360biolabs Acquisition

by Rajaneesh K. Gopinath
Share To
After establishing its footprint in the west, Durham-based BioAgilytix Labs is looking to broaden its presence on the other side of the world. On August 16th, the leading global contract research laboratory announced plans to buy Australian CRO 360biolabs for an undisclosed amount.

BioAgilytix is currently operating in two US locations; Durham, North Carolina, and Boston, Massachusetts. Besides, it also has a laboratory in Hamburg, Germany. With the latest acquisition of 360biolabs, the company aims to extend its services to customers in Melbourne, Victoria.

GO Prime with only $1.49 now

LATEST
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
Discrimination Leads to Rapid Aging, Science Shows the Detrimental Effects of this Act
2024-05-17
A New Study has Linked Treatment Resistant Depression to Body Mass Index
2024-05-16
AI Reveals Sex-Related Brain Differences and Precision Medicine Potential
2024-05-16
The EU Sustainability Directive’s Influence on Pharmaceutical Supply Chains
2024-05-15
New UC Berkeley Study Challenges Traditional Views on Lactate and Carbohydrate Metabolism
2024-05-15
First Person to Receive Transplanted Pig Kidney has Died
2024-05-13
EVENT
Scroll to Top